These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 12034361)

  • 1. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
    Li Z; Mei Y; Liu X; Zhou M
    Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
    EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
    Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
    Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells.
    Gordon-Thomson C; Jones J; Mason RS; Moore GP
    Melanoma Res; 2005 Feb; 15(1):21-8. PubMed ID: 15714117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell death induced by TNF or serum starvation is independent of ErbB receptor signaling in MCF-7 breast carcinoma cells.
    Egeblad M; Jäättelä M
    Int J Cancer; 2000 Jun; 86(5):617-25. PubMed ID: 10797281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.
    Bouyain S; Longo PA; Li S; Ferguson KM; Leahy DJ
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15024-9. PubMed ID: 16203964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.
    Mill CP; Gettinger KL; Riese DJ
    Exp Cell Res; 2011 Feb; 317(4):392-404. PubMed ID: 21110957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells.
    Fiddes RJ; Janes PW; Sanderson GM; Sivertsen SP; Sutherland RL; Daly RJ
    Cell Growth Differ; 1995 Dec; 6(12):1567-77. PubMed ID: 9019162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4.
    Wang LM; Kuo A; Alimandi M; Veri MC; Lee CC; Kapoor V; Ellmore N; Chen XH; Pierce JH
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6809-14. PubMed ID: 9618494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
    Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
    Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression.
    Sundaresan S; Roberts PE; King KL; Sliwkowski MX; Mather JP
    Endocrinology; 1998 Dec; 139(12):4756-64. PubMed ID: 9832411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand discrimination in signaling through an ErbB4 receptor homodimer.
    Sweeney C; Lai C; Riese DJ; Diamonti AJ; Cantley LC; Carraway KL
    J Biol Chem; 2000 Jun; 275(26):19803-7. PubMed ID: 10867024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling.
    Wandinger SK; Lahortiga I; Jacobs K; Klammer M; Jordan N; Elschenbroich S; Parade M; Jacoby E; Linders JT; Brehmer D; Cools J; Daub H
    PLoS One; 2016; 11(1):e0146100. PubMed ID: 26745281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of an ErbB3- and ErbB4-specific ligand screening system, and a screen of neuregulin-1 mutants].
    Qi Y; Wei DZ; Liu XF; Zhou MD
    Yi Chuan; 2010 Dec; 32(12):1247-55. PubMed ID: 21513150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB; Hynes NE; Lane HA
    Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
    Lee H; Akita RW; Sliwkowski MX; Maihle NJ
    Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.
    Fitzpatrick VD; Pisacane PI; Vandlen RL; Sliwkowski MX
    FEBS Lett; 1998 Jul; 431(1):102-6. PubMed ID: 9684874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ERBB3/ERBB2 oncogenic unit plays a key role in NRG1 signaling and melanoma cell growth and survival.
    Zhang K; Wong P; Duan J; Jacobs B; Borden EC; Bedogni B
    Pigment Cell Melanoma Res; 2013 May; 26(3):408-14. PubMed ID: 23480537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.